This review explored the complex mechanisms of NK cell activation, involving various receptors such as NKG2D, CD16, and CD69, and their role in mediating processes such as ADCC in respiratory system cancers and also the challenges respiratory system tumors pose in evading NK cell‐mediated immune responses. The gene discussed is CD69; the disease is respiratory system cancer.